High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
Expands manufacturing push & locks in major growth deals
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
Subscribe To Our Newsletter & Stay Updated
